About Richard Knight

Dr Richard Knight PhD, ERT. A co-founder of ApconiX, Richard is an expert toxicologist with more than 20 years of drug development experience gained in AstraZeneca, where he was part of the Drug Safety and Oncology Leadership Teams. Richard has worked on projects in multiple therapy areas involving small molecules, biologics, proteins and oligonucleotides. He has an in-depth understanding of drug discovery and drug development and has been directly involved in bringing over 35 new candidate drugs to clinical trials and 6 to marketing approval. He uses his extensive experience to bring an innovative, science-led and pragmatic approach to the design and delivery of nonclinical safety programmes.

ApconiX Welcomes Susan Tantawi

ApconiX Welcomes Susan Tantawi ApconiX is delighted to welcome Susan Tantawi who joins the Project Toxicology team and will be working with Dr Richard Knight.  Based in Montreal in Canada, Susan has over fifteen years’ experience working in CROs, consultancies and biotechnology companies.  With broad toxicology expertise, Susan also [...]

By |2024-03-20T15:32:00+00:00March 15th, 2024|Company News, Toxicology, Careers|Comments Off on ApconiX Welcomes Susan Tantawi

Professor Ruth Roberts Joins the NC3Rs NAMs Advisory Group

Professor Ruth Roberts Joins the NC3Rs NAMs Advisory Group Professor Ruth Roberts has joined the NC3Rs NAMs (new approach methodologies) Advisory Group which supports the NAMs Network by providing expert insight and advice. Ruth commented, “We are passionate about replacing the use of animals in drug safety at ApconiX [...]

By |2024-03-15T15:30:09+00:00March 12th, 2024|Company News, Toxicology|Comments Off on Professor Ruth Roberts Joins the NC3Rs NAMs Advisory Group

ApconiX Welcomes Donna Martin

ApconiX Welcomes Donna Martin ApconiX is delighted to welcome Donna Martin who joins the Finance team as Finance and Administration Assistant and will be working with Louisa Lake. Career Donna worked for AstraZeneca for thirty years, working in Human Resources commenting, “Although that seems a long time, in those [...]

By |2024-02-13T15:10:18+00:00February 13th, 2024|Company News, Careers|Comments Off on ApconiX Welcomes Donna Martin

ApconiX Welcomes Dr Haroon Rashid

ApconiX Welcomes Dr Haroon Rashid ApconiX is delighted to welcome Dr Haroon Rashid who joins us as a Senior Toxicologist and will be working with Dr Richard Knight. Haroon has worked at a number of CROs as Study Director, working in General, Development and Reproductive, and Chemical Toxicology. Career [...]

By |2024-03-20T15:53:47+00:00January 25th, 2024|Company News, Toxicology, Careers|Comments Off on ApconiX Welcomes Dr Haroon Rashid

ApconiX Welcomes Joanne Wilson

ApconiX Welcomes Joanne Wilson ApconiX is delighted to welcome Joanne Wilson who joins as a Project Manager and will be working with Dr Richard Knight. With over 20 years’ experience as a DMPK scientist and project manager at AstraZeneca, Jo has led cross-functional teams and driven the efficient development [...]

By |2023-10-20T10:24:25+01:00August 29th, 2023|Company News, Careers|Comments Off on ApconiX Welcomes Joanne Wilson

ApconiX Welcomes Stacey Owen

ApconiX Welcomes Stacey Owen ApconiX is delighted to welcome Stacey Owen who joins the Project Management team and will be working with Dr Richard Knight. Stacey has considerable business development experience and will also be supporting Dr Laurence Bishop, our Head of Business Development. Career Stacey graduated from Cardiff [...]

By |2023-10-20T10:29:12+01:00August 29th, 2023|Company News, Careers|Comments Off on ApconiX Welcomes Stacey Owen

ApconiX Welcomes Maxine Xodo-Rose

ApconiX Welcomes Maxine Xodo-Rose ApconiX is delighted to welcome Maxine Xodo-Rose to ApconiX as a Finance & Admin Assistant. Maxine has returned to work after a short career break to look after a young family and will be working with Louise Lake. Career Maxine graduated from the University of [...]

By |2023-03-15T16:13:17+00:00March 15th, 2023|Company News, Careers|Comments Off on ApconiX Welcomes Maxine Xodo-Rose

ApconiX Welcomes Sarah Pass

ApconiX Welcomes Sarah Pass ApconiX is delighted to welcome Sarah Pass who joins the team of nonclinical DMPK experts and will be working with Dr Richard Knight.  With a career in both industry and contract research, Sarah is an experienced drug metabolism and pharmacokinetics (DMPK) scientist with experience of [...]

By |2023-02-23T11:16:05+00:00December 6th, 2022|Company News, Toxicology, Careers|Comments Off on ApconiX Welcomes Sarah Pass

Lean Life Science and Cancer Research UK Launch the Oncology Development Programme (ODP2) to Accelerate Development of High Impact Novel Cancer Innovations

Lean Life Science and Cancer Research UK Launch the Oncology Development Programme (ODP2) to Accelerate Development of High Impact Novel Cancer Innovations ApconiX is very excited to be part of Oncology Development Programme2 (ODP2) the latest Development Programme launched on the 21st of November at Alderley Park focused on [...]

By |2022-11-29T09:22:45+00:00November 28th, 2022|Company News|Comments Off on Lean Life Science and Cancer Research UK Launch the Oncology Development Programme (ODP2) to Accelerate Development of High Impact Novel Cancer Innovations
Go to Top